Safety Study of SEA-CD40 in Cancer Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02376699 |
|
Recruitment Status :
Terminated
(Study closed due to portfolio prioritization)
First Posted : March 3, 2015
Last Update Posted : May 1, 2023
|
Sponsor:
Seagen Inc.
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Seagen Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | March 6, 2023 |
| Actual Study Completion Date : | April 14, 2023 |